Skip to Main Content
Table I.

Components and doses of vaccination in the rhIL-12 dose ranging experiment (Expt. 1) and in the HKLV/alum dose ranging experiment (Expt. 2)

Expt.aComponents and Doses
1a Saline 
1b Alum (0.5 mg)+ rhIL-12 (1 μg) 
1c HKLV (1 mg) 
1d HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (0.04 μg) 
1e HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (0.2 μg) 
1f HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (1 μg) 
2a Saline 
2b HKLV (1 mg)+ rhIL-12 (2 μg) 
2c HKLV (1 mg)+ alum (0.5 mg) 
2d HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (2 μg) 
2e HKLV (0.5 mg)+ alum (0.25 mg)+ rhIL-12 (2 μg) 
2f HKLV (0.25 mg)+ alum (0.125 mg)+ rhIL-12 (2 μg) 
Expt.aComponents and Doses
1a Saline 
1b Alum (0.5 mg)+ rhIL-12 (1 μg) 
1c HKLV (1 mg) 
1d HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (0.04 μg) 
1e HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (0.2 μg) 
1f HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (1 μg) 
2a Saline 
2b HKLV (1 mg)+ rhIL-12 (2 μg) 
2c HKLV (1 mg)+ alum (0.5 mg) 
2d HKLV (1 mg)+ alum (0.5 mg)+ rhIL-12 (2 μg) 
2e HKLV (0.5 mg)+ alum (0.25 mg)+ rhIL-12 (2 μg) 
2f HKLV (0.25 mg)+ alum (0.125 mg)+ rhIL-12 (2 μg) 
a

Four macaques in each group were injected once s.c. in the arm with the indicated components diluted to 0.5 ml with PBS.

Close Modal

or Create an Account

Close Modal
Close Modal